Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Sanofi & Cheplapharm Form Strategic Partnership

Pharmaceutical Executive Daily: Sanofi & Cheplapharm Form Strategic Partnership

Published 2 months ago
Description
GSK is acquiring a trispecific T-cell engager from Chimagen Biosciences and Sanofi expanding its manufacturing partnership with Cheplapharm, Stewart Gandolf discusses why pharma marketing now has to write for both people and AI, and Dr. Elena Christofides explains why cortisol dysregulation may be the hidden reason some diabetes patients fail to respond to incretin therapies.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us